233 related articles for article (PubMed ID: 17971175)
1. Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice.
Hamelet J; Aït-Yahya-Graison E; Matulewicz E; Noll C; Badel-Chagnon A; Camproux AC; Demuth K; Paul JL; Delabar JM; Janel N
Eur J Clin Invest; 2007 Dec; 37(12):933-8. PubMed ID: 17971175
[TBL] [Abstract][Full Text] [Related]
2. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice.
Noll C; Hamelet J; Matulewicz E; Paul JL; Delabar JM; Janel N
J Nutr Biochem; 2009 Aug; 20(8):586-96. PubMed ID: 18676137
[TBL] [Abstract][Full Text] [Related]
3. Taurine-deficient diet up-regulated cystathionine beta-synthase monoallele in hemizygous cystathionine beta-synthase knockout mice.
Chao WH; Reynolds RD
Nutr Res; 2009 Nov; 29(11):794-801. PubMed ID: 19932868
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice.
Wang L; Jhee KH; Hua X; DiBello PM; Jacobsen DW; Kruger WD
Circ Res; 2004 May; 94(10):1318-24. PubMed ID: 15105297
[TBL] [Abstract][Full Text] [Related]
5. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway.
Alberto JM; Hamelet J; Noll C; Blaise S; Bronowicki JP; Guéant JL; Delabar JM; Janel N
Mol Genet Metab; 2007 Aug; 91(4):396-8. PubMed ID: 17562377
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver.
Janel N; Christophe O; Aït Yahya-Graison E; Hamelet J; Paly E; Prieur M; Delezoïde AL; Delabar JM
Biochem Biophys Res Commun; 2006 Aug; 346(4):1303-6. PubMed ID: 16806076
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice.
Noll C; Hamelet J; Ducros V; Belin N; Paul JL; Delabar JM; Janel N
Food Chem Toxicol; 2009 Jan; 47(1):230-6. PubMed ID: 19028542
[TBL] [Abstract][Full Text] [Related]
8. Hyperkeratosis in cystathionine beta synthase-deficient mice: an animal model of hyperhomocysteinemia.
Robert K; Maurin N; Ledru A; Delabar J; Janel N
Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):1072-6. PubMed ID: 15386278
[TBL] [Abstract][Full Text] [Related]
9. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels.
Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; van Oppenraay-Emmerzaal D; den Heijer M; Trijbels FJ; Blom HJ
Eur J Hum Genet; 2001 Aug; 9(8):583-9. PubMed ID: 11528503
[TBL] [Abstract][Full Text] [Related]
10. Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice.
Hamelet J; Demuth K; Dairou J; Ledru A; Paul JL; Dupret JM; Delabar JM; Rodrigues-Lima F; Janel N
Biochem Biophys Res Commun; 2007 Mar; 355(1):221-7. PubMed ID: 17292331
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.
Hamelet J; Demuth K; Paul JL; Delabar JM; Janel N
J Hepatol; 2007 Jan; 46(1):151-9. PubMed ID: 17030070
[TBL] [Abstract][Full Text] [Related]
12. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
[TBL] [Abstract][Full Text] [Related]
13. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.
Akahoshi N; Kobayashi C; Ishizaki Y; Izumi T; Himi T; Suematsu M; Ishii I
Hum Mol Genet; 2008 Jul; 17(13):1994-2005. PubMed ID: 18364386
[TBL] [Abstract][Full Text] [Related]
14. Effect of nephrotic syndrome on homocysteine metabolism.
Aminzadeh MA; Gollapudi P; Vaziri ND
Nephrol Dial Transplant; 2011 Apr; 26(4):1244-7. PubMed ID: 20826746
[TBL] [Abstract][Full Text] [Related]
15. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients.
Heil SG; Riksen NP; Boers GH; Smulders Y; Blom HJ
Mol Genet Metab; 2007 May; 91(1):55-60. PubMed ID: 17336565
[TBL] [Abstract][Full Text] [Related]
17. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.
Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP
Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice.
Tlili A; Jacobs F; de Koning L; Mohamed S; Bui LC; Dairou J; Belin N; Ducros V; Dubois T; Paul JL; Delabar JM; De Geest B; Janel N
Biochim Biophys Acta; 2013 Jun; 1832(6):718-28. PubMed ID: 23429073
[TBL] [Abstract][Full Text] [Related]
19. Protection and reversal of hepatic fibrosis by red wine polyphenols in hyperhomocysteinemic mice.
Noll C; Raaf L; Planque C; Benard L; Secardin L; Petit E; Dairou J; Paul JL; Samuel JL; Delcayre C; Rodrigues-Lima F; Janel N
J Nutr Biochem; 2011 Sep; 22(9):856-64. PubMed ID: 21185709
[TBL] [Abstract][Full Text] [Related]
20. Genetically based hypertension generated through interaction of mild hypoalphalipoproteinemia and mild hyperhomocysteinemia.
Carnicer R; Navarro MA; Arbonés-Mainar JM; Arnal C; Surra JC; Acín S; Sarría A; Blanco-Vaca F; Maeda N; Osada J
J Hypertens; 2007 Aug; 25(8):1597-607. PubMed ID: 17620955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
